Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 17 Issue: 4, May 2017



Meet Our Editorial Board Member free to download

Volume:17   Issue: 4
Pp: 303-303
Thomas W. Grunt*
DOI: 10.2174/156800961704170419204900
Published on: 19 April, 2017



Synthetic Lethal Interactions in Cancer Therapy

Volume:17   Issue: 4
Pp: 304-310
Xinwei Geng, Xiaohui Wang, Dan Zhu* and Songmin Ying*
DOI: 10.2174/1568009616666160426122736
Published on: 26 April, 2016




Chemotherapy and Cardiotoxicity in Hematologic Malignancies

Volume:17   Issue: 4
Pp: 311-324
Antonio Stellitano, Roberta Fedele, Santina Barilla, Antonino Iaria, Carmelo Massimiliano Rao and Massimo Martino*
DOI: 10.2174/1568009617666161121141607
Published on: 21 November, 2016




The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer

Volume:17   Issue: 4
Pp: 325-332
Vladimir Stanislavovich Rogovskii*
DOI: 10.2174/1568009617666170109110816
Published on: 08 January, 2017




New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias

Volume:17   Issue: 4
Pp: 333-343
Weronika Bereza, Joanna Szczepanek*, Joanna Laskowska and Andrzej Tretyn
DOI: 10.2174/1568009616666161208150148
Published on: 08 December, 2016




Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy

Volume:17   Issue: 4
Pp: 344-356
Heena Singla, Sourav Kalra, Preeti Kheterpal, Vinod Kumar* and Anjana Munshi*
DOI: 10.2174/1568009616666161216094026
Published on: 15 December, 2016




Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials

Volume:17   Issue: 4
Pp: 357-375
Bhupinder Kumar, Rakesh Kumar, Ira Skvortsova* and Vinod Kumar*
DOI: 10.2174/1568009616666160928110818
Published on: 28 September, 2016




Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway

Volume:17   Issue: 4
Pp: 376-385
Ruzhen Zheng, Hao Jiang*, Jinhui Li, Xinge Liu and Hongwei Xu
DOI: 10.2174/1568009616666161213141608
Published on: 13 December, 2016




Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells

Volume:17   Issue: 4
Pp: 386-401
Qiaohua Zhu, Xinfa Yu, Zhi-Wei Zhou, Chengyu Zhou, Xiao-Wu Chen* and Shu-Feng Zhou*
DOI: 10.2174/1568009616666160630182344
Published on: 30 June, 2016